Inderjeet Singh
@inderjeet.singh.3636
Indore
10+ Years of experience
SEBI Registration INH000016144
Trade Ideas
58
Opinions
52
Followers
325
Expertise
Quantitative
Growth
Technical
Index Strategies
Market Commentary
Futures & Options
Technical Analysis
Trade Facts
Total Trades
0
Missed Trades
0
Profit Trades
0
0%Accuracy
Ask me Anything
Got a question? Ask me and I will answer it. Stay curious, stay hungry!
Posts
shared an insight ⚡️ 11th Sep
Milky Mist Shares Hit Record High, Rise 75% From Low
MILKYMIST
Dairy Food shares hit a record high on September 11, rising 3.4% to ₹288.80 after the company commissioned a new Skyr and Greek Yogurt manufacturing facility in Tamil Nadu. The stock has surged 75% from its 52-week low of ₹165, reflecting strong momentum since its August IPO.
The new facility, located at the company’s integrated manufacturing unit in Perundurai, has been set up with an investment of around ₹40 crore and can process up to 150 tonnes per day using Ultrafiltration Technology. Milky Mist said demand for the category has grown by more than 50% annually, while demand for high-protein yogurts has more than doubled in recent months.
Strong financial performance has also supported the rally. In Q1FY27, Milky Mist’s consolidated revenue from operations rose 43.6% YoY to ₹973.45 crore, while PAT jumped 889.81% to ₹64.68 crore. EBITDA increased 74.5% to ₹144.89 crore, with the margin improving to 14.88%. The company expects the capacity expansion to improve product availability, support revenue growth and strengthen its position in India’s growing high-protein dairy market. shared an insight ⚡️ 10th Sep
Biocon Shares Rise 3% After ₹635 Crore Block Deal
BIOCON
shares gained up to 3% after around 1% of the company’s equity changed hands in a ₹635-crore block deal. The stock also gained support from management commentary that its biosimilars business could soon reach $1 billion in revenue, driven by strong demand for insulin and newer products.
Around 1.65 crore Biocon shares were traded on the BSE at ₹385 per share, taking the transaction value above ₹635 crore. The block deal price was around 1.9% below the previous closing price. True North-owned Active Pine was reported to be the likely seller, with the investor holding a 1.08% stake as of June 30.
Separately, Biocon said it expects double-digit revenue growth in its biosimilars business and is targeting margins in the mid-20% range. The company is seeing strong demand for insulin, while newer products such as aflibercept are adding to growth prospects. Biocon has not committed to a specific timeline for reaching the $1 billion revenue milestone. shared an insight ⚡️ 9th Sep
Maruti Suzuki August Sales Jump 35% YoY to 1.77 Lakh Units
MARUTI
reported a 34.8% year-on-year increase in domestic passenger vehicle sales to 1,76,971 units in August 2026, compared with 1,31,278 units a year earlier. The strong performance was supported by robust demand across its key models, with WagonR and Swift among the best-selling cars during the month.
WagonR sales rose around 39% YoY to 20,180 units, while Swift sales increased sharply by about 60% during August. Maruti Suzuki also maintained a strong presence in the country's top-selling car rankings, with several of its models featuring among the leading performers.
The strong monthly performance comes as India's auto market enters the festive season, traditionally a key period for vehicle demand. Industry-wide vehicle retail sales also reached a record August level, while consumers increasingly shifted towards CNG, hybrid and electric vehicles. Maruti's strong sales growth therefore highlights continued demand for its passenger vehicle portfolio despite changing fuel preferences and higher vehicle prices.FAQ's
What are the top stock recommendations by Inderjeet Singh?
Inderjeet Singh regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include Britannia Industries Ltd. (Bullish), MILKYMIST, BIOCON and MARUTI. Explore Inderjeet Singh's complete list of posts and trade views on their StockGro profile.
How can I follow Inderjeet Singh's latest investment insights?
You can follow Inderjeet Singh's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.
What is Inderjeet Singh's investment strategy?
Inderjeet Singh follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.
How long has Inderjeet Singh been a SEBI-registered Research Analyst (RA)?
Inderjeet Singh has been a SEBI-registered Research Analyst and have 10+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.
Where can I see Inderjeet Singh's past performance and stock picks?
You can check Inderjeet Singh's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.
How can I contact Inderjeet Singh for stock market advice?
For stock market guidance from Inderjeet Singh, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.
What is Inderjeet Singh's track record in predicting market movements?
Inderjeet Singh has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.
What is the SEBI Registration number for Inderjeet Singh?
Inderjeet Singh is a SEBI-registered Research Analyst with the SEBI Registration INH000016144. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.
Be Financially Free with StockGro